Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

An Effectiveness and Safety Study Evaluating OROS Methylphenidate Hydrochloride (HCl), Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder

This study has been completed.
Information provided by:
Alza Corporation, DE, USA Identifier:
First received: December 22, 2005
Last updated: July 8, 2011
Last verified: July 2011